Led by an interest in GLP-1 weight loss drugs, more health care brands may advertise in the Super Bowl this year.

Factors contributing to the ramifications of this disease as it stands include the socio-economic: overweight and obesity ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

There are options to renew your health regimen that do not have to be overwhelming or too costly. Whether you are trying to ...

Companies such as Teladoc and Omada Health have embraced GLP-1s while dangling the prospect of lowered costs to their ...

Online pharmacies will need a proper consultation, not just a patient's questionnaire, to prescribe jabs such as Mounjaro ...

People wanting to buy weight loss jabs online are to face stricter checks after some with eating disorders were given ...

Pharmacists must verify a person’s body mass index (BMI) via a video consultation, in person, or through accessing GP or medical records.

Advertisements In today’s world of weight management, quick fixes often overshadow sustainable solutions. The rise in popularity of GLP-1 drugs for weight loss, while offering promising results, falls ...

GLP-1 medications have become popular for weight loss, and for good reason—they can help regulate appetite and support weight ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.